Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

China neurosurgery robotic surgical systems market poised for 12% CAGR through 2033, forecasts GlobalData

China’s healthcare sector is witnessing substantial investment in robotic technologies, driven by an increasing demand for advanced medical solutions. Against this background, China’s neurosurgery robotic surgical systems market is projected to grow at a compound annual growth rate (CAGR) of 12% between 2023 and 2033, according to GlobalData, a leading data and analytics company. GlobalData’s […]
Read more

Energy harvesting tech transforms IoT and consumer electronics with sustainable power, says GlobalData

Energy harvesting technologies are set to transform IoT and consumer electronics by providing sustainable, efficient, and innovative power solutions. These advancements aim to significantly reduce reliance on traditional batteries, addressing environmental concerns and enhancing device performance. By offering eco-friendly alternatives, these technologies promise to extend device lifespan, reduce maintenance costs, and transform power sources in […]
Read more

Tapinarof may mark Dermavant’s first atopic dermatitis approval, says GlobalData

Dermavant’s VTAMA (tapinarof), a nonsteroidal, topical AhR-modulating agent, achieved positive Phase III trial results in atopic dermatitis patients aged two and above, leading to FDA acceptance of its supplemental new drug application (sNDA). The promising results may bring Dermavant’s VTAMA closer to market authorization and will be its first atopic dermatitis marketed drug, subject to […]
Read more

Apple AI races up to Google and Microsoft, says GlobalData

Following the news (10 June) that Apple has introduced Apple Intelligence, the personal intelligence system that puts powerful generative models at the core of iPhone, iPad, and Mac at the Worldwide Developer Conference (WWDC) 2024; Anisha Bhatia, Senior Technology Analyst at GlobalData, a leading data and analytics company, offers her view: “Apple is no longer […]
Read more

Next generation sequencers market in India to grow at 11% CAGR through 2033, forecasts GlobalData

Next generation sequencing (NGS) is increasingly being applied in clinical oncology to advance personalized treatment of cancer. Technological advancements are driving a surge in the adoption of NGS in India, enhancing patient care and guiding more accurate and specific screening and targeted therapies. Against this backdrop, India’s next generation sequencers market is expected to grow […]
Read more

China leads APAC in institute-led clinical trials, reveals GlobalData

With the evolving landscape of drug development and innovations, several institutes are serving as catalysts by partnering with pharmaceutical companies to drive progress at various stages of research and development. These collaborations are particularly significant in advancing clinical trials, a critical step in drug development. Against this backdrop, within the Asia-Pacific (APAC) region, China leads […]
Read more

Cybersecurity companies discuss AI integration for enhanced risk management, finds GlobalData

Artificial intelligence (AI) is playing a significant role in the field of cybersecurity. It has the potential to enhance organizations’ incident response capabilities. Cybersecurity companies have been discussing incorporating AI capabilities in various areas, including incident response, threat detection, and prediction capabilities according to the Company Filings Analytics Database of GlobalData, a leading data and […]
Read more

BIOSECURE Act forces US pharma to reevaluate China manufacturing reliance, says GlobalData

As the BIOSECURE Act progresses through the US legislative process, the US pharmaceutical industry finds itself at a crossroads. With heavy reliance on Chinese contract manufacturers, US companies are reevaluating their partnerships amidst the proposed regulations aimed at safeguarding national security interests. While the Act remains a topic of debate, some anticipate potential onshoring benefits, […]
Read more

Roche’s Vabysmo further showcases stronghold across wAMD and DME spaces, says GlobalData

Roche has recently presented post-hoc analysis results of the TENAYA (NCT03823287) and LUCERNE (NCT03823300) trials of Vabysmo (faricimab), a VEGF and Ang2 inhibitor, at the Association for Research in Vision and Ophthalmology (ARVO) conference. The data not only showcases Vabysmo’s efficacy in wet age-related macular degeneration (wAMD) and diabetic macular edema (DME) but also the […]
Read more

Biosimilar market poised for significant growth in the coming years, says GlobalData

The rise of biologics has revolutionized treatments for traditionally hard-to-treat diseases, leading to the growth of the biosimilar market. As more biologics lose patent protection, the influx of biosimilars is set to expand, offering cost-effective alternatives and significantly impacting their respective markets. This dynamic shift promises broader access to critical therapies, according to GlobalData, a […]
Read more

Future business success hinges on sustainability and circular economy practices, says GlobalData

As public demand for climate action and resource conservation grows, businesses must pivot to sustainability to thrive. Embracing circular economy principles, such as reducing waste and extending product lifecycles, is crucial. As a result, future success hinges on adopting innovative technologies and sustainable practices, ensuring businesses remain efficient, compliant, and resilient in an evolving regulatory […]
Read more

Neurology remains key therapeutic area for Japan pharma majors, says GlobalData

In the dynamic landscape of healthcare, key neurological disorders like Alzheimer’s disease, epilepsy, Parkinson’s disease, and depression pose significant challenges, particularly in the Asia-Pacific (APAC) region, where prevalence is high. The World Health Organization stated in March 2024 that “over 80% of neurological deaths and health losses occur in low- and middle-income countries, and access […]
Read more

China semiconductor ambitions trigger concerns over market oversupply, reveals GlobalData

China’s unveiling of $47.5 billion state-backed semiconductor investment fund has sparked conversations among influencers on “X” platform during the last week of May 2024. Influencers perceive the move as a strategic effort to shift the competitive landscape, in the wake of trade tensions with the US, but worry about potential market oversupply, price volatility, and […]
Read more
1 … 62 63 64 65 66 … 209